Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Cometti

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|September 6, 2015
Pharmaceutical and clinical development of a novel progesterone formulationBarbara Cometti
Human Reproduction Open|March 22, 2019
Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcomeGeorg Griesinger, Silvia Trevisan, Barbara Cometti
Clinical Drug Investigation|February 9, 2022
Randomized Pharmacokinetic Study of a Highly Purified Human Chorionic Gonadotropin and of a Recombinant Human Chorionic Gonadotropin Following Single Subcutaneous Administration in Healthy WomenMilko Radicioni, Chiara Leuratti, Barbara Cometti
Fertility and Sterility|October 22, 2013
Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled studyGillian Lockwood, Georg Griesinger, Barbara Cometti, et al.
Clinical Pharmacology in Drug Development|July 13, 2023
Comparative Bioavailability of Two Daily Subcutaneous Doses Versus a Single Dose of Intramuscular and Vaginal Progesterone Formulations in Healthy Postmenopausal FemalesMario Tanguay, Barbara Cometti, Sylvie Boudreault
Plos One|March 19, 2016
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III TrialsJakob Doblinger, Barbara Cometti, Silvia Trevisan, et al.
Biology of Reproduction|May 2, 2003
Oviduct cells express the cyclic AMP-adenosine pathwayBarbara Cometti, Raghvendra K Dubey, Bruno Imthurn, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 17, 2007
Elaboration of a working model for the involvement of inhibin A as a mediator of the preovulatory rise of progesterone levelsChristian De Geyter, Sabine Steimann, Peter Huber, et al.
Biology of Reproduction|February 28, 2003
Differential effects of natural and environmental estrogens on endothelin synthesis in bovine oviduct cellsKarin C Reinhart, Raghvendra K Dubey, Barbara Cometti, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|April 6, 2017
Assessment of the immunogenicity of gonadotrophins during controlled ovarian stimulationCarles Morte, Carles Celma, Christian De Geyter, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Acta Obstetricia Et Gynecologica Scandinavica|September 6, 2015
Pharmaceutical and clinical development of a novel progesterone formulationBarbara Cometti
Human Reproduction Open|March 22, 2019
Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcomeGeorg Griesinger, Silvia Trevisan, Barbara Cometti
Clinical Drug Investigation|February 9, 2022
Randomized Pharmacokinetic Study of a Highly Purified Human Chorionic Gonadotropin and of a Recombinant Human Chorionic Gonadotropin Following Single Subcutaneous Administration in Healthy WomenMilko Radicioni, Chiara Leuratti, Barbara Cometti
Fertility and Sterility|October 22, 2013
Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled studyGillian Lockwood, Georg Griesinger, Barbara Cometti, et al.
Clinical Pharmacology in Drug Development|July 13, 2023
Comparative Bioavailability of Two Daily Subcutaneous Doses Versus a Single Dose of Intramuscular and Vaginal Progesterone Formulations in Healthy Postmenopausal FemalesMario Tanguay, Barbara Cometti, Sylvie Boudreault
Plos One|March 19, 2016
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III TrialsJakob Doblinger, Barbara Cometti, Silvia Trevisan, et al.
Biology of Reproduction|May 2, 2003
Oviduct cells express the cyclic AMP-adenosine pathwayBarbara Cometti, Raghvendra K Dubey, Bruno Imthurn, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 17, 2007
Elaboration of a working model for the involvement of inhibin A as a mediator of the preovulatory rise of progesterone levelsChristian De Geyter, Sabine Steimann, Peter Huber, et al.
Biology of Reproduction|February 28, 2003
Differential effects of natural and environmental estrogens on endothelin synthesis in bovine oviduct cellsKarin C Reinhart, Raghvendra K Dubey, Barbara Cometti, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|April 6, 2017
Assessment of the immunogenicity of gonadotrophins during controlled ovarian stimulationCarles Morte, Carles Celma, Christian De Geyter, et al.
Pageof 2